R. Berkery

Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors.

N. Kemeny, L. Saltz, A. Dietz, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Taxol and Recombinant Human Granulocyte Colony‐Stimulating Factor, an Active Regimen as Initial Therapy for Metastatic Breast Cancer

C. Hudis, L. Norton, S. Arbuck, 1993, Annals of the New York Academy of Sciences.

Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.

M. Kris, M. J. Nolte, R. Berkery, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oncology Pocket Guide to Chemotherapy

A. Skarin, R. Berkery, Lorraine Baltzer Cleri, 1994 .

9‐aminocamptothecin by 72‐hour continuous intravenous infusion is Inactive in the treatment of patients with 5‐fluorouracil‐refractory colorectal carcinoma

N. Kemeny, L. Saltz, D. Kelsen, 1997, Cancer.